GlassScriptPhysician profile
Lance K Burns
NPI 1023286051
$27,405.66
in general payments reported to CMS, 2019-2025
34 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $8,379 · 2021: $414 · 2022: $131 · 2023: $486 · 2024: $351 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,371.74 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $358.27 | 2021-2025 | Interstim, Signia |
| Smith+Nephew, INC. | $170.31 | 2019-2023 | Renasys Go V2 Home |
| Davol INC. | $152.82 | 2023-2024 | Arista Ah Flexitip |
| Zyla Life Sciences, INC. | $137.35 | 2019-2020 | |
| Baudax Bio INC. | $133.69 | 2021 | |
| Merck Sharp & Dohme LLC | $129.09 | 2019-2021 | |
| Boston Scientific Corporation | $89.31 | 2019-2025 | Axonics |
| Integra Lifesciences Corporation | $83.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.36 | 2023 | Gattex |
| Intercept Pharmaceuticals, INC. | $63.36 | 2019 | |
| Acera Surgical, INC. | $57.59 | 2019-2022 | |
| Acell, INC. | $50.24 | 2019 | |
| Innovation Technologies INC | $49.75 | 2022-2023 | Irrisept |
| Ethicon US, LLC | $45.02 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $43.15 | 2020 | |
| Ferring Pharmaceuticals INC. | $42.54 | 2023-2024 | Rebyota |
| Tela Bio, INC. | $34.00 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Myriad Genetic Laboratories, INC. | $33.25 | 2025 | Myrisk |
| Edwards Lifesciences Corporation | $26.92 | 2024 | Hemosphere |
| Teleflex LLC | $26.08 | 2024 | Quikclot |
| Urgo Medical North America, LLC | $25.47 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Nestle Healthcare Nutrition INC. | $23.53 | 2023 | |
| Mauna Kea Technologies, INC. | $21.21 | 2021 | |
| Solventum Corporation | $18.82 | 2025 | V.A.C. Veraflo Cleanse Choice, Abthera, Prevena |
| Coloplast Corp | $18.24 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $17.93 | 2025 | |
| Ambu INC. | $17.02 | 2022 | |
| Medline Industries LP | $16.68 | 2019 | |
| Polynovo North America LLC | $16.66 | 2024 | Novosorb Btm |
| W. L. Gore & Associates, INC. | $16.34 | 2025 | Gore Enform Intraperitoneal Biomaterial |
| Axonics, INC. | $14.52 | 2022 | |
| Conmed Corporation | $14.06 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.